JAMA Network
About The Study: This cross-sectional study of patients with de novo metastatic breast cancer (dnMBC) found racial and ethnic disparities in disease presentation and inequities in timely treatment for dnMBC across subtypes, emphasizing the need for tailored interventions to improve care delivery and outcomes. De novo metastatic breast cancer, defined as the presence of distant metastases at initial diagnosis, accounts for only 5.4% to 10.0% of new cases but disproportionately contributes to breast cancer mortality in the U.S.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
